James Robl
Listed on 1 Form D filing across 1+ issuer
· Executive Officer
Associated issuers
- Immuno Cancer Biotherapeutics, Inc. CIK 2158173 · SD
Filings (1)
-
Immuno Cancer Biotherapeutics, Inc.D · Oct 15, 2026 · SD · Biotechnology